Učitavanje...

Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying anti‐rheumatic drugs for rheumatoid arthritis: A network meta‐analysis

BACKGROUND: Methotrexate is considered the preferred disease‐modifying anti‐rheumatic drug (DMARD) for the treatment of rheumatoid arthritis, but controversy exists on the additional benefits and harms of combining methotrexate with other DMARDs. OBJECTIVES: To compare methotrexate and methotrexate‐...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Cochrane Database Syst Rev
Glavni autori: Hazlewood, Glen S, Barnabe, Cheryl, Tomlinson, George, Marshall, Deborah, Devoe, Daniel JA, Bombardier, Claire
Format: Artigo
Jezik:Inglês
Izdano: John Wiley & Sons, Ltd 2016
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7087436/
https://ncbi.nlm.nih.gov/pubmed/27571502
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD010227.pub2
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!